Drug discovery: creating a new ecosystem

2 June 2016 09:00 - 3 June 2016 18:00, Oxford, United Kingdom

This provocative meeting is intended to bring together all those concerned about drug discovery (academia, industry, biotech, funders, charities and patient groups) to openly debate the bottlenecks that are hindering innovation and generation of tangible results. Our vision is to establish practical opportunities to map and create better, more efficient approaches for this quickly-evolving ecosystem.

The conference will consist of six panels discussing different scientific and strategic challenges, each composed by three panellists and two chairs. Individual talks by the panellists will be followed by critical and direct questioning by the chairs, who will encourage audience participation.

Drug discovery: creating a new ecosystem: Programme

Day 1 , 2nd June 2016 :
Plenary talk I
Session 1:
"The new era of genomics and big data: will it deliver this time?"
Session 2: "Phenotypic screening and human tissue platforms: a new fad or a transformational tool for reliable target validation?"
Session 3: "The impact of chemical biology in drug discovery: how far can we push it?"

Day 2 , 3rd June 2016 :
Plenary talk II
Session 4:
"Antibiotics and neglected diseases: ripe opportunities to create open source medicines/ pharma?"
Session 5: "The birth of a new ecosystem: who are the new actors and are the traditional ones obsolete?"
Session 6: "New therapeutic strategies: beyond conventional biologics and medicinal chemistry"

Closing session
  • Dr Mark Bunnage Vice President, Worldwide Medicinal Chemistry - Pfizer, United States
  • Sir David Cooksey Chairman of the Board, The Francis Crick Institute, United Kingdom
  • Mr Clive Cookson Science Editor, Financial Times, United Kingdom
  • Prof Jim Davies Chief Technology Officer, Genome England, United Kingdom
  • Dr Joerg Eder Exec Director,Novartis Institutes for Biomedical Research, Switzerland
  • Prof Aled Edwards Director - SGC, Canada
  • Prof Ulrike Eggert Professor in Chemical Biology - King's College London, United Kingdom
  • Prof Mike Ferguson Regius Prof & Assoc Dean for Research Strategy, U. Dundee, United Kingdom
  • Prof Ted Fon Scientific Director - Montreal Neurological Institute, Canada
  • Dr Alastair Lawson Vice President, Structural Biology, UCB, United Kingdom
  • Dr Hugh Laverty Head of Scientific Operations, IMI, United Kingdom
  • Dr Monika Lessl Vice President, Head of Innovation Strategy, Bayer, Germany
  • Prof Gil McVean Acting Director, Oxford Big Data Institute, United Kingdom
  • Dr Pierre Meulien Executive Director, IMI, Belgium
  • Dr Bernard Munos Senior Fellow, FasterCures, and Founder, ‎InnoThink, United States
  • Dr Henrik Oerum Vice President, Chief Scientific Officer, Roche, Denmark
  • Dr Michael Sundstrom Scientific Director, ULTRADD, Karolinska Institute, Sweden
  • Dr Leticia Toledo-Sherman Director CADD & Med Chem, CHDI Foundation, United States
  • Prof Paul Workman Chief Executive & President, Inst Cancer Research, United Kingdom

University of Oxford, Mathematical Institute

University of Oxford, Mathematical Institute, Andrew Wiles Building , Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, United Kingdom

Organised by
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry